Multi‐omics analyses reveal distinct molecular characteristics and transformation mechanisms of stage I–<scp>III</scp> micropapillary lung adenocarcinoma
The micropapillary (MIP) pattern is a high-grade histological subtype of lung adenocarcinoma (LUAD) with poor prognosis. In this study, surgically resected tumor samples from 101 patients with stage I-III MIP-LUAD (MIP ≥30%) were microdissected to separate MIP components from non-MIP components, all of which underwent RNA and DNA whole-exome sequencing (WES). The genomic and transcriptomic landscapes of MIP and non-MIP components within MIP-enriched tumor tissues demonstrated remarkable similarities, notably marked by high epidermal growth factor receptor (EGFR) alteration frequencies. However, when compared to MIP-naïve LUAD tissues, MIP components showed higher chromosomal instability and revealed 18 enriched alterations, encompassing EGFR mutations, EGFR amplifications, and CDKN2A/CDKN2B deletions, which all linked to upregulation of cell proliferation pathways and downregulation of immune pathways. Shared mutations were observed in 97.8% (91/93) of patients with paired DNA WES data for MIP and non-MIP components within the same tissues, suggesting a common origin. The recurrence-free survival analysis identified MACF1, PCLO, ADGRV1, and Fanconi Anemia pathway mutations as negative indicators. In all, we conducted an in-depth analysis of the molecular characteristics and transformation mechanisms of MIP-LUAD, employing microdissection techniques to investigate the genomic and transcriptomic levels within a substantial cohort, providing insights for precision medicine of this aggressive cancer subtype. © 2025 The Pathological Society of Great Britain and Ireland.
Authors
- Xiaoli Feng (ORCID: https://orcid.org/0000-0002-7188-884X)
- Shugeng Gao (ORCID: https://orcid.org/0000-0003-1888-2622)
- Bo Zheng (ORCID: https://orcid.org/0000-0002-1496-0753)
- Qiuxiang Ou (ORCID: https://orcid.org/0000-0002-2961-2057)
- Jiaohui Pang (ORCID: https://orcid.org/0009-0003-0689-560X)
- Fengwei Tan (ORCID: https://orcid.org/0000-0002-8210-684X)
- Anqi Shao
- Qi Xue (ORCID: https://orcid.org/0000-0002-5086-4654)
- Yang Qu (ORCID: https://orcid.org/0000-0003-3757-3497)
- Wei Zheng (ORCID: https://orcid.org/0000-0003-3193-2655)
- Hanlin Chen (ORCID: https://orcid.org/0000-0001-6205-3122)
- Kang Shao (ORCID: https://orcid.org/0009-0000-0655-5371)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Columbia University (US)
Publication Details
- Journal
- The Journal of Pathology
- Published
- 2025-03-28
- DOI
- https://doi.org/10.1002/path.6416
- Citations
- 2
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 3.04